| Product Code: ETC8539185 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Gastric Cancer Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Gastric Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Gastric Cancer Market - Industry Life Cycle |
3.4 Netherlands Gastric Cancer Market - Porter's Five Forces |
3.5 Netherlands Gastric Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Gastric Cancer Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 Netherlands Gastric Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Netherlands Gastric Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Netherlands Gastric Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Netherlands Gastric Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Netherlands Gastric Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Gastric Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastric cancer in the Netherlands |
4.2.2 Advancements in diagnostic technologies leading to early detection |
4.2.3 Growing adoption of minimally invasive surgical procedures |
4.2.4 Rising healthcare expenditure and focus on cancer treatment |
4.2.5 Collaborations between research institutions and pharmaceutical companies for new treatment options |
4.3 Market Restraints |
4.3.1 High cost of cancer treatment and lack of reimbursement options |
4.3.2 Limited availability of specialized healthcare facilities for gastric cancer treatment |
4.3.3 Regulatory challenges in the approval process for new therapies |
4.3.4 Increasing competition from alternative treatment options like immunotherapy |
4.3.5 Lack of awareness about gastric cancer symptoms and risk factors among the population |
5 Netherlands Gastric Cancer Market Trends |
6 Netherlands Gastric Cancer Market, By Types |
6.1 Netherlands Gastric Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Gastric Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Netherlands Gastric Cancer Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.1.4 Netherlands Gastric Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 Netherlands Gastric Cancer Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F |
6.1.6 Netherlands Gastric Cancer Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F |
6.1.7 Netherlands Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Gastric Cancer Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Gastric Cancer Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.3 Netherlands Gastric Cancer Market Revenues & Volume, By Stage II, 2021- 2031F |
6.2.4 Netherlands Gastric Cancer Market Revenues & Volume, By Stage III, 2021- 2031F |
6.2.5 Netherlands Gastric Cancer Market Revenues & Volume, By Stage IV, 2021- 2031F |
6.2.6 Netherlands Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Gastric Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Gastric Cancer Market Revenues & Volume, By Endoscopy, 2021- 2031F |
6.3.3 Netherlands Gastric Cancer Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.4 Netherlands Gastric Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.3.5 Netherlands Gastric Cancer Market Revenues & Volume, By Exploratory Surgery, 2021- 2031F |
6.3.6 Netherlands Gastric Cancer Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Netherlands Gastric Cancer Market, By Treatment |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Gastric Cancer Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 Netherlands Gastric Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Netherlands Gastric Cancer Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.5 Netherlands Gastric Cancer Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.6 Netherlands Gastric Cancer Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.4.7 Netherlands Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Gastric Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Gastric Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Netherlands Gastric Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Netherlands Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Netherlands Gastric Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Gastric Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Netherlands Gastric Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Netherlands Gastric Cancer Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.6.5 Netherlands Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Netherlands Gastric Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Netherlands Gastric Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Netherlands Gastric Cancer Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 Netherlands Gastric Cancer Market Revenues & Volume, By , 2021- 2031F |
7 Netherlands Gastric Cancer Market Import-Export Trade Statistics |
7.1 Netherlands Gastric Cancer Market Export to Major Countries |
7.2 Netherlands Gastric Cancer Market Imports from Major Countries |
8 Netherlands Gastric Cancer Market Key Performance Indicators |
8.1 Survival rates of patients diagnosed with gastric cancer |
8.2 Adoption rates of new diagnostic technologies for gastric cancer screening |
8.3 Number of clinical trials conducted for innovative gastric cancer treatments |
8.4 Patient satisfaction scores with the quality of care received for gastric cancer |
8.5 Rate of early-stage diagnosis of gastric cancer in the Netherlands |
9 Netherlands Gastric Cancer Market - Opportunity Assessment |
9.1 Netherlands Gastric Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Gastric Cancer Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 Netherlands Gastric Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Netherlands Gastric Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.5 Netherlands Gastric Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Netherlands Gastric Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Netherlands Gastric Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Gastric Cancer Market - Competitive Landscape |
10.1 Netherlands Gastric Cancer Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Gastric Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here